Skip to main content
. 2013 May 8;3:108. doi: 10.3389/fonc.2013.00108

Figure 1.

Figure 1

Schematic representation of PI3K pathway and sites of action of PI3K signaling pathway inhibitors in solid tumors and hematological malignancies.